BRIC Countries (Brazil, Russia, India, China) Pharmaceuticals Market Summary, Competitive Analysis and Forecast, 2018-2027


Summary

The BRIC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Key Highlights

  • Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the pharmaceuticals industry and had a total market value of $289.7 billion in 2022. China was the fastest growing country with a CAGR of 12.2% over the 2018-22 period.
  • Within the pharmaceuticals industry, China is the leading country among the BRIC nations with market revenues of $213.2 billion in 2022. This was followed by Russia, India and Brazil with a value of $31.9, $24.2, and $20.4 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the BRIC nations with a value of $355.2 billion in 2027, followed by Russia, India, Brazil with expected values of $40.0, $32.6 and $20.0 billion, respectively.




Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC pharmaceuticals market with five year forecasts
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country




Reasons To Buy

  • What was the size of the BRIC pharmaceuticals market by value in 2022?
  • What will be the size of the BRIC pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the BRIC pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the BRIC pharmaceuticals market?